GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » PB Ratio

CAMP (Camp4 Therapeutics) PB Ratio : (As of Mar. 24, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-24), Camp4 Therapeutics's share price is $5.3557. Camp4 Therapeutics's Book Value per Share for the quarter that ended in Sep. 2024 was $-8.15. Hence, Camp4 Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Camp4 Therapeutics's PB Ratio or its related term are showing as below:

CAMP's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.41
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Camp4 Therapeutics PB Ratio Historical Data

The historical data trend for Camp4 Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics PB Ratio Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23
PB Ratio
- -

Camp4 Therapeutics Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Camp4 Therapeutics's PB Ratio

For the Biotechnology subindustry, Camp4 Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's PB Ratio falls into.



Camp4 Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Camp4 Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=5.3557/-8.15
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Camp4 Therapeutics  (NAS:CAMP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Camp4 Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.